DOCSLIB.ORG

Organization 1889 Foundation, Inc. AARP/Life Reimagined Institute

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Organization 1889 Foundation, Inc. AARP/Life Reimagined Institute Organization 1889 Foundation, Inc. AARP/Life Reimagined Institute Abbvie Abington Jefferson Health Abington Memorial Hospital Abington-Jefferson Health Accenture Accenture Health Management Accountable Health, LLC Accreditation Association for Ambulatory Health Care Adventist HealthCare Advocate Sherman Hospital Aetna Agency for Healthcare Research and Quality Agile Health Akron General Health System Akron General Medical Center - a Cleveland Clinic affiliate Albany Medical Center Alston & Bird, LLP American College of Preventive Medicine American Medical Association American Psychological Association AmeriHealth Caritas Amgen Anesthesia Services, P.A. AnMed Health Lakeside Family Medicine Ann & Robert H. Lurie Children's Hospital of Chicago Anne Arundel Medical Center Aria Health Aria Health Physician Services Arizona State University Arnot Health Assurex Health Astellas Medical Affairs Astellas Medical Affairs Americas Astellas Pharma AstraZeneca athenahealth athenahealth, Inc. Atlantic Health System Atlanticare Atrius Health System Audience Partners, llc. Aultman Hospital Austin Regional Clinic Avera Medical Group Axiom Systems AXIOM Systems, Inc. AxisPoint Health Baker Tilley Capital, LLC Baltimore City Health Department Baptist Health BayCare Health System Beebe Healthcare Better Medicare Alliance Bluespire BlueSpire Strategic Marketing Boehringer Ingelheim Boehringer-Ingelheim Boehringer-Ingelheim Pharmaceuticals Boehringer-Ingelheim Pharmaceuticals Inc Booz Allen Hamilton Brind Investments Partners, Inc. Bureau of TennCare Camden Coalition of Healthcare Providers Canary Health CareCentrix CareMount Medical, PC Carle Foundation Hospital Carolinas HealthCare System Catholic Health Services of Long Island CBH Centering Healthcare Institute Central Maine Medical Group CentraState Healthcare System Cerner Corporation Chapman Health Solutions, LLC Chase Brexton Health Care Children's Hospital of Philadelphia Chilmark Research Christiana Care Health System Christiana Care Medical Home Without Walls Christus Health Cigna Cigna Healthcare Citigroup Citrus Valley Health Partners Cleveland Clinic Community Care of North Carolina Community Medical Centers Comprehensive Health Concord Hospital Concord Hospital, Concord, NH Cooper University Health Care Cooper University Healthcare Crozer Crozer Keystone Family Residency Program Crozer-Keystone Family Medicine Residency Program CVS Health CVS Health Corporation Dartmouth Hitchcock Dartmouth Hitchcock Health Dartmouth Hitchcock Medical Center Dartmouth-Hitchcock Dartmouth-Hitchcock Medical Center David Geffen School of Medicine at UCLA Delaware Valley Accountable Care Organization Delaware Valley ACO Delmont Healthcare Deloitte Consulting LLP Deloitte LLP Department of Health | Office of the Secretary DePaul Univ Doylestown Health Drexel University Drexel University College of Medicine ECRI Institute Einstein Healthcare Network Encare Entree Health Princeton Envision Healthcare Corporation Epic Epic Systems Ernst & Young LLP Esperanza Health Center EviCore eviCore healthcare Evolution Health Evolution Health - Envision Healthcare, Inc. EwingCole Express Scripts Family Business Magazine Family Practice Associates of Upper Dublin FDB Fisher & Paykel Healthcare Florida International University Forecast Health Franciscan Physician Network Fraser Street Medical & Vane Divisions Frederick Memorial Fudan University Gallup GBS Corp. Geisinger Health System Foundation Genentech Genentech, Inc. Genesis HealthCare Good Measures Government of the NWT, Dept of Health and Social Services Graduate School of Kyushu University, Department of Health Care And Administrati GrayHare Ventures LLC Great River Health Systems Griffin Hospital Hackensack University Health Network HackensackUMC Harris Allen Group, LLC HC Wisdom, LLC Health Alliance Health Care Service Corporation Health Economy, LLC Health Innovation Media Health IT, Patient Safety, and Quality Consulting Health Partners Plans Healthcare Informatics Magazine Healthcare Transformation Healthgrades HealthNEXT Healthways, Inc. Healthwise Healthy Howard, Inc. Hearst Business Media Hearst Health Heritage Valley Health System Hill-Rom Company HMR/Merck Holon Solutions Home Solutions Humana Humana Government Business Humana Inc. Humana, Inc. IBM IBM Corporation IBM Watson Health Ideal healthcare. Solutions Imperial Health IndigoJLD Green Health InfoMC Inc. Informatics Corporation of America Innovation In Medtech LLC Inspira Health Network Intel Care Innovations InterComponentWare (ICW), Inc. InterComponentWare Inc. InterComponentWare, Inc. Jack Welch Management Institute Janssen Janssen Biotech, Inc Janssen Oncology Janssen Scientific Affairs Janssen, Johnson & Johnson Jefferson Center for Urban Health Jefferson College of Population Health Jefferson Health Jefferson Physicians Jersey City Medical Center-Barnabas Health John Snow, Inc. Johnson & Johnson Johnson and Johnson Kaiser Permanente Kantar Health Kaufman Hall Kennedy Health System Kent State University, College of Public Health Lehigh Valley Health Network Life Laboratory Lilly USA, LLC Look at Myrtle Beach Lourdes Health System Health Network Lumeris Main Line Health Main Line Health System Mary Ann Liebert Publishers, Inc. Mary Ann Liebert, Inc. Maryland Department of Health and Mental Hygiene Matrix Medical Network Mayo Clinic MCG MedCity News Medecision Medencentive Medical College of Wisconsin Medical Economics Medical Home Without Walls Christiana Care medSolis MedStar Franklin Square Medical Center MedWorks Consulting Merced County Rescue Mission Merck Merck & Co Merck & Co, Inc. Merck & Co. Inc. Merck & Co., Inc. Merck Vaccines Merck/HMR Mercy Health Methodist Hospital, Jefferson Health MGMA Millennium Collaborative Care PPS/ECMCC Mission Point Health Partners Molina Healthcare Mount Kisco Medical Group, PC MultiCare Health System MVP Health Care National Association for Healthcare Quality National Kidney Foundation Navigate NCQA NJAFP Nordic Consulting Novo Nordisk Numerof & Associates Numerof & Associates, Inc. NYU Lutheran Family Health Centers O'Connor Hospital OcuHub Omada Health Optum Opus Partners Osage Investments, Inc. PA House of Representatives Palmetto Health Park Avenue Medical Partners in Integrated Care Partnership for a Healthier Carroll County PatientsLikeMe Penn State University Pennsylvania Department of Health Perelman School of Medicine at U of PA Pershing Yoakley & Associates Philadelphia University Philanthropy Office of Institutional Advancement Philips Philips Respironics Phytel, An IBM Company Pinnacle Claims Management Inc Pinnacol Assurance Planetree PMHCC Populytics Premise Health PricewaterhouseCoopers Princeton HealthCare System ProgenyHealth PYA Qlik Quillen ETSU Physicians Quorum Health Resources Reading Health Partners Reading Health System RedBrick Health RelateCare Renaissance Health Network Robert Wood Johnson Foundation Robert Wood Johnson University Hospital Rosalind Franklin University Rothman Institute Rutgers Camden Sage Growth Partners Salkowitz Associates, LLC Sanofi Saul Ewing LLP SCI Solutions SCIO Health Analytics Seattle Cancer Care Alliance Sharecare Sharp Rees-Stealy Simpler Simpler Healthcare SKMC/Nemours AI duPont Hospital for Children Sodexo Southcentral Foundation SP Consulting Sparrow Health System SPH Analytics SRG Technology St Joseph Hoag Health St. Christopher's Hospital for Children St. Christopher's Pediatric Associates Stamford Hospital State of CT Dept. Public Health Strategic Health Policy International, Inc Suffolk Care Collaborative/Stony Brook Medicine Sutter Health Synaptic AP Temple Health Temple Physicians, Inc. Temple University Temple University Health System Teva Pharmaceuticals Texas Woman's University The Access Group The Baxter Family Foundation The Center for Case Management The Centers for Families and Children The Childrens Hospital of Philadelphia The Children's Hospital of Philadelphia The Christ Hospital The College of New Jersey The Coordinating Center The Health Federation of Philadelphia The University of Alabama The University of Texas MD Anderson Cancer Center Thomas Jefferson University Thomas Jefferson University and Jefferson Health Thomas Jefferson University and Jefferson Health Thomas Jefferson University Hospital Thomas Jefferson University Hospitals TJUH Transcend TreVia Digital Health Trinity Health Trion Group Truven Health Analytics Tufts University School of Medicine Turn-Key Health UConn School of Pharmacy UMR - Main Line Health UnitedHealthcare University of California, Santa Barbara University of Detroit University of Louisville Physicians University of Maryland Faculty Physicians, Inc. University of New Mexico University of Pennsylvania University of the Sciences University or Arkansas for Medical Sciences US ARMY Fort Leonard Wood, Mo US Preventive Medicine UTMB Health Valence Health Validation Institute Valley Health Valley Healthlink Valley Organized Physicians Vanderbilt University Medical Center Veralon Vestagen Technical Textiles Virtua Virtua Health Virtua Medical Group Vizient, Inc. VNA Health Group WellCare Health Plans WellCare Health Plans Inc Wellcentive Wellmed Medical Group WellMed of DFW Wells Fargo Advisors, LLC Welltok Welltok, Inc. Wellville Winkenwerder Strategies, LLC Wired Magazine WPS Health Insurance ZeOmega Zynx Health Position @eFuturist 2 Reads Way Account Executive Account Management Account Services Executive Account Supervisor Acting Director of Healthcare Analytics and Business Intelligence, Assistant Dir Actuarial Informatics Analyst Adjunct Faculty
Load more

Recommended publications
  • Drug Safety Oversight Board Members
    April 29, 2021 Drug Safety Oversight Board (DSOB) Roster Chair • Douglas Throckmorton, M.D., Deputy Director for Regulatory Programs Center for Drug Evaluation and Research Executive Director • Terry Toigo, R.Ph, MBA Associate Director for Drug Safety Operations, Center for Drug Evaluation and Research Food and Drug Administration Center for Drug Evaluation and Research (CDER) Office of the Center Director (OCD) Primary Member: • Robert Temple, M.D., Deputy Director for Clinical Science Office of New Drugs (OND) Primary Member: • Mary Thanh Hai, M.D., Deputy Director, Office of New Drugs Alternate Members: • Peter Stein, M.D., Director, Office of New Drugs • Ellis Unger, M.D., Director, Office of Office of Cardiology, Hematology, Endocrinology, and Nephrology (OCHEN) Office of Medical Policy (OMP) Primary Member: • Jacqueline Corrigan-Curay, Director Alternate Member: • Leonard V. Sacks, Mgr. Supervisory Medical Officer Office of Generic Drugs (OGD) Primary Member: • Linda Forsyth, M.D., Division of Clinical Review Alternate Member: • Vacant Office of Surveillance and Epidemiology (OSE) Primary Members: • Mark I. Avigan, M.D., Associate Director for Critical Path Initiatives • Judy Zander, M.D., Director, Office of Pharmacoviligance and Epidemiology (OPE) Alternate Members: • Gerald DalPan, M.D., M.H.S., Director, OSE • S. Chris Jones, Deputy Director, Division of Pharmacovigilance (DPV) II • Judy Staffa, Ph.D., R.Ph., Associate Director for Public Health Initiatives -Page 1 of 4- April 29, 2021 • Cynthia LaCivita, R.Ph, Director, Division
    [Show full text]
  • When Mentoring Matters
    careers & recruitment People Recent moves of note in and around the biotech and pharma industries. over 20 years of experience in the pharma Clinical-stage biopharma Humanigen has announced the industry, including significant gene therapy appointment of Adrian Kilcoyne (photo) to the newly created translational and development expertise. role of chief medical officer. He brings leadership experience Reape was most recently chief medical from multinational pharma and biotech companies and a officer at Spark Therapeutics. strong clinical background in internal medicine and public health medicine, having recently served as vice president of Clinical-stage precision medicine oncology global medical affairs, head of evidence generation company Relay Therapeutics has named and external alliances at AstraZeneca. Patrick Riley senior vice president of “Dr. Kilcoyne’s experience and knowledge in multiple areas, including COVID-19, artificial intelligence. Riley has over a CAR-T and other oncology clinical development areas, medical affairs, regulatory affairs, decade of data science and machine learning evidence generation, health economics and partnering, gives him a unique insight that can experience from Google, initially in web be leveraged towards Humanigen’s COVID-19, acute GvHD, CAR-T and other oncology search and user behavior analysis and programs with lenzilumab and ifabotuzumab,” said Humanigen CEO Cameron Durrant. later as a principal engineer and senior “In addition, Adrian’s leadership in the external alliances arena will be instrumental in researcher on the Google Accelerated helping guide the progress of Humanigen’s pipeline and potential commercialization.” Science team. In addition, Relay has appointed Charles Ferté, formerly AstraZeneca’s senior director and global project leader of oncology R&D, as its Laura Carter has been appointed CSO of Precision metagenomics company vice president and lead for RLY-4008, a Gossamer Bio, succeeding Luisa Salter-Cid.
    [Show full text]
  • Public Health Act
    Province of Alberta PUBLIC HEALTH ACT Revised Statutes of Alberta 2000 Chapter P-37 Current as of June 17, 2021 Office Consolidation © Published by Alberta Queen’s Printer Alberta Queen’s Printer Suite 700, Park Plaza 10611 - 98 Avenue Edmonton, AB T5K 2P7 Phone: 780-427-4952 Fax: 780-452-0668 E-mail: [email protected] Shop on-line at www.qp.alberta.ca Copyright and Permission Statement Alberta Queen's Printer holds copyright on behalf of the Government of Alberta in right of Her Majesty the Queen for all Government of Alberta legislation. Alberta Queen's Printer permits any person to reproduce Alberta’s statutes and regulations without seeking permission and without charge, provided due diligence is exercised to ensure the accuracy of the materials produced, and Crown copyright is acknowledged in the following format: © Alberta Queen's Printer, 20__.* *The year of first publication of the legal materials is to be completed. Note All persons making use of this consolidation are reminded that it has no legislative sanction, that amendments have been embodied for convenience of reference only. The official Statutes and Regulations should be consulted for all purposes of interpreting and applying the law. Amendments Not in Force This consolidation incorporates only those amendments in force on the consolidation date shown on the cover. It does not include the following amendments: RSA 2000 cP-37 s77 repeals ss1(1)(e.1) and (2), 33(2.1) and (2.2), 52.6(1.1)(c) and (1.2), 52.61, 52.92 to 52.992, 53(4.2) to (4.4), 53.1 to 53.4, 66(2)(r), 76.
    [Show full text]
  • April 7, 2021 Message from Chief Medical Officer on COVID-19
    From: Chief Medical Officer Subject: Message from Chief Medical Officer on COVID-19 Vaccine Availability Date: Wednesday, April 7, 2021 6:08:49 PM Attachments: image001.png April 7, 2021 Message from Chief Medical Officer on COVID-19 Vaccine Availability Dear Colleagues, Earlier this week, President Biden announced the timeline for all U.S. adults to be eligible for the COVID-19 vaccine was moved up to April 19, from the original goal of May 1. That means that in just over a week, any adult in our country who wants a vaccine will be eligible to register for one. This news brings us hope and encouragement that we are on the right path to defeat the pandemic. I want to provide as many resources as possible to help you navigate the various pathways for getting the vaccine. As a DHS employee, there are several roads to vaccination. Mission-essential, location-dependent (1A/1B) employees were provided an opportunity to receive the vaccine through our partnership with the Veterans Health Administration (VHA). Currently, 163 VA Medical Centers (VAMCs) across the country are scheduling and vaccinating those 1A/1B employees who opted in. DHS employees also have several options to locate vaccine opportunities in their communities through VaccineFinder.org or local retail pharmacies. NEW: All non-1A/1B DHS employees may present this designation letter to their local vaccine provider immediately as proof of priority eligibility to receive the COVID-19 vaccine as part of the Centers for Disease Control and Prevention’s Phase 1C (essential workforce) recommendation. Note: This designation letter is not for use as part of our VHA partnership, as the VAMCs are completing vaccinations for DHS 1A/1B colleagues only.
    [Show full text]
  • Global Pharmaceutical and Medical Meetings Summit ™
    The 4th Annual Global Pharmaceutical and Medical Meetings Summit ™ February 10-12, 2016 - Philadelphia, PA Final Attendee List TRANSPARENCY STATEMENT: This is the final attendee list for this event. It is not a compiled list of alumni from previous years. TITLE COMPANY Natl Sales Mgr A Gift Inside Specailized Pharmacist Abbott Global Healthcare & Research Sr Specialist Procurement Abbott Laboratories Sr Partner AG Communications Sr Partner AG Communications Event Coordinator AHM Global Director Strategic Meeting Mgmt AHM Global VP Compliance & Strategic Solutions AHM Sr Event Manager AHM SVP Global Strategic Account Mgmt AHM Bus Mgr AIM Grp Intl Managing Dir AIM Grp Intl New York Office Account Dir AIMIA Account Dir Aimia Account Supv AIMIA Mgr Program Operations Aimia Purchasing Mgr / Channel & Employee Loyalty Aimia Strategy & Client Planning Dir Aimia VP Client Svcs Aimia Dir Exposition American College of Cardiology Mgr Bus Dev Strategic Meetings American Express Global Strategic Account Mgr American Express GBT Meeting Mgr American Express Global Business Travel Strategic Account Manager, Americas American Express Global Business Travel Strategic Account Mgr American Express Global Business Travel Project & Meetings Mgr R&D HCP American Express Meetings & Events Director Compliance Operations ARIAD PHARMACEUTICALS INC Account Dir Ashfield Meetings & Events Bus Dev Dir Ashfield Meetings & Events CEO Americas Ashfield Meetings & Events VP Commercial Ops Ashfield Meetings & Events Assoc Astrazeneca Global Category Mgr Meetings & Events
    [Show full text]
  • Market Update M&Amarlin & Associates Investment Banking and Strategic Advisory to the Technology and Information Industries
    March 2019 MARKET UPDATE M&AMARLIN & ASSOCIATES INVESTMENT BANKING AND STRATEGIC ADVISORY TO THE TECHNOLOGY AND INFORMATION INDUSTRIES New York Washington, D.C. Toronto www.MarlinLLC.com © Marlin & Associates Holdings LLC, All Right Reserved DEAR CLIENTS AND FRIENDS, It’s About Revenue Synergies, Stupid: Our March Infotech M&A update Dear Clients and Friends, Please see below for our March Infotech m&a report. As many of you know, over the past 17+ years we have advised on more than 200 successful m&a transactions. We use the term “successful” to mean that the deal completed. But we recognize that investors and acquirers assess if a transaction was “successful” in hindsight. For a financial sponsor, the answer eventually becomes clear. For them, it’s all about exit value. But for a strategic acquirer the answer can be more amorphous - it’s all about whether the acquired firm added enough value to the combined firm to justify the cost – It’s not only about the purchase price, it’s also about the distraction and the disruption – and that means realizing “synergies”. A few months ago, EY- Parthenon put out an insightful series of articles on successful m&a integration. They noted that [for strategic acquirers] “… the identification and realization of synergies are at the heart of M&A value creation”. “…Synergies can be the competitive advantage in a bidding process.” And “… they are a major part of the narrative that executives use to explain the strategic objectives of a transaction to their own boards, shareholders and the market.” Clearly, it is the potential for synergies that can allow one strategic to outbid another (or a financial sponsor).
    [Show full text]
  • Global Health, Epidemiology and Genomics
    global health, epidemiology and genomics HEALTH CARE SYSTEMS ORIGINAL RESEARCH ARTICLE Competency of peripheral health workers in detection & management of common syndromic conditions under surveillance, North 24 Parganas, West Bengal, India, 2016: a cross-sectional study F. Debnath1,2*, T. Bhatnagar3, L. Sundaramoorthy3 and M. Ponnaiah3 1 Division of Epidemiology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, West Bengal, India 2 Masters of Public Health Scholar, ICMR-National Institute of Epidemiology, Chennai, India 3 ICMR School of Public Health, ICMR-National Institute of Epidemiology, Chennai, India Global Health, Epidemiology and Genomics (2017), 2, e15, page 1 of 8. doi:10.1017/gheg.2017.13 Background Competency of peripheral health workers in the detection and management of common syndromic condi- tions is crucial as they are the first point of contact for the majority of the Indian population. Methods We measured the competency of auxiliary nurse midwives (ANMs), and factors associated with inadequate competency, in the detection and management of common conditions diarrhoea,̶ acute respiratory tract infection, fever, malaria through̶ a cross-sectional study using condition specific validated clinical vignettes and structured questionnaires. Results Out of 272 selected ANMs, 68% (95% CI 62–74%) were adequately competent. Factors independently associated with inadequate competency were unavailability of essential drugs in preceding month [adjusted odds ratio (AOR) = 1.95; 95% CI 1.1–3.5] and ever trained in integrated management of childhood illness (AOR = 2.4; 95% CI 1.4–4.1). Conclusion More than two third of the peripheral health workers were adequately competent to detect and manage com- mon conditions.
    [Show full text]
  • Assetmark Names Natalie Wolfsen Chief Executive Officer Michael Kim
    AssetMark Names Natalie Wolfsen Chief Executive Officer Michael Kim Appointed President CONCORD, Calif., February 23, 2021 – AssetMark Financial Holdings, Inc. (NYSE: AMK) today announced that its Board of Directors has named Natalie Wolfsen as the company’s new Chief Executive Officer and Michael Kim as its new President. Both appointments are effective as of March 3, 2021. Ms. Wolfsen and Mr. Kim are succeeding Charles Goldman, who will be leaving his role as President and Chief Executive Officer and as a member of the Board of Directors. Mr. Goldman will assist in the transition by serving as a consultant to the company for one year. Ms. Wolfsen will also join the AssetMark Board of Directors. Ms. Wolfsen, who most recently served as AssetMark’s Executive Vice President and Chief Solutions Officer, brings to her new position more than 25 years of experience in investment product management, investments, digital product development and marketing, as well as a proven track record of successfully achieving business results for AssetMark. She is an experienced strategist, consistently and successfully identifying and meeting the evolving needs of financial advisors and their clients through the development of new technology and services. “Natalie is a proven, high-performing leader who the Board of Directors unanimously believes is the right executive to lead AssetMark moving forward,” said Xiaoning Jiao, Chairperson of the AssetMark Board of Directors. “She brings to her new role a deep knowledge of AssetMark, a track record of successfully developing and leading teams and a forward-looking approach that promotes holistic advisor-client conversations, innovative technology and greater diversity and inclusion in the wealth management industry.
    [Show full text]
  • MEI Pharma Announces the Retirement of Chief Medical Officer
    MEI Pharma Announces the Retirement of Chief Medical Officer Robert Mass and Promotion of Richard Ghalie to Chief Medical Officer SAN DIEGO, April 30, 2021 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP) ("MEI"), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the retirement of Robert Mass, M.D., MEI's chief medical officer. Dr. Mass joined the company in 2010 and will retire on May 3, 2021, after which he will continue to serve as a strategic advisor to the company. The Company also announced that Richard Ghalie, M.D., MEI's senior vice president, clinical development, has been promoted to chief medical officer. "Bob's contributions to MEI over his more than ten years at the company have been invaluable across our drug candidate pipeline, particularly in guiding the strategy and broad clinical development program for zandelisib, which will best be measured by the benefit these programs may ultimately provide to patients. I want to thank Bob for his dedication to MEI and his friendship over these past 10 years. We wish him the very best in his retirement and look forward to continued interaction through his advisory role," said Daniel P. Gold, Ph.D., president and chief executive officer of MEI Pharma. "I also welcome Richard stepping into his role as our new chief medical officer, a role for which he is very well suited, as evidenced by the significant progress in our zandelisib program under Richard's guidance and its progress with our partners at Kyowa Kirin towards zandelisib's planned new drug application for consideration by FDA for approval under the accelerated approval pathway." Dr.
    [Show full text]
  • Business Strategy Business Results Financial Section Journey So Far Journey Ahead Sustainability
    Konica Minolta’s Konica Minolta’s Platform Supporting Business Strategy Business Results Financial Section Journey So Far Journey Ahead Sustainability Business Strategy Boosting the earning potential of core businesses while further expanding growth businesses and new businesses Business Toshimitsu Taiko Strategy Senior Executive Officer 1 Lead officer responsible for Business Technologies Business Roman Tihelka We will boost the earning potential Managing Director, Cluster East, Boosting Business Technologies of core businesses, with a focus on Konica Minolta developing stronger long-term Business Solutions Europe GmbH relationships with customers. Business Profitability Ramping up our IT services for a greater presence Core Growth in Eastern Europe. Business Hitoshi Kamezawa Douglas Kreysar Strategy 2 Executive Officer Chief Solutions Officer, General Manager, Radiant Vision Systems Sensing Business unit, Industrial Optical System Leveraging the assets of the Business Headquarters Growth Strategies for the Konica Minolta Group, Utilizing technologies for measuring we will continue to provide light and color, Konica Minolta high quality, innovative pursues genre-top strategies for the solutions. Measuring Instruments Business ICT and automotive industries. Core Growth Business Kiyotaka Fujii Strategy Senior Managing Executive Officer 3 General Manager, Healthcare Business Headquarters Jack Hoppin We will build a global business Growth Strategies for the management system and CEO, Invicro LLC accelerate business strategies for the precision
    [Show full text]
  • Directory of State and Local Government
    DIRECTORY OF STATE AND LOCAL GOVERNMENT Prepared by RESEARCH DIVISION LEGISLATIVE COUNSEL BUREAU 2020 Table of Contents TABLE OF CONTENTS Please refer to the Alphabetical Index to the Directory of State and Local Government for a complete list of agencies. NEVADA STATE GOVERNMENT ORGANIZATIONAL CHART ............................................. D-9 CONGRESSIONAL DELEGATION ............................................................................................. D-13 DIRECTORY OF STATE GOVERNMENT CONSTITUTIONAL OFFICERS: Attorney General ........................................................................................................................ D-15 State Controller ........................................................................................................................... D-19 Governor ..................................................................................................................................... D-20 Lieutenant Governor ................................................................................................................... D-27 Secretary of State ........................................................................................................................ D-28 State Treasurer ............................................................................................................................ D-30 EXECUTIVE BOARDS ................................................................................................................. D-31 NEVADA SYSTEM OF HIGHER EDUCATION
    [Show full text]
  • First Name Last Name Job Title Company Type Company Name Hank Beaver VP, Group Account Director Ad Tech
    First Name Last Name Job Title Company_Type Company Name Hank Beaver VP, Group Account Director Ad Tech - Platform 360i Kristen Baker VP Ad Tech - Platform 360i Heather Chancey Account Director Ad Tech - Platform 360i Blake Ivie Director, Integrated Media Ad Tech - Platform 360i Michaela Haswell Associate Media Manager Ad Tech - Platform 360i Marla Kaplowitz CEO Trade Body 4A's R Lee Barstow VP Revenue Operations Publisher A+E Networks Joe Catanzaro VP, Revenue Operations & Yield Ad Tech - Platform a4 media pty Dan Riccio VP, Advertising Insights & Ad Operations Publisher Al Jazeera Cooper Greene Agency Partnerships Ad Tech - Platform Ampersand Megan Kasler Associate Director of Marketing & Communications Media Agency Amplifi USA/ dentsu Timothy Chung Technical Account Manager Media Agency Annalect Anny Buakaew Director Media Agency Annalect Nicole Lewis Associate Director Media Agency Annalect Kristopher Schmelzer Senior Account Manager Media Agency Annalect Ashley Lai Senior Account Manager Media Agency Annalect Genie Gilder Assistant Vice President Marketing Advertiser Aon Corporation Delia O'Donnell Buyer Ad Tech - Platform APEX EXCHANGE, LLC Jason Wulfsohn COO & Co-Founder Ad Tech - Platform AUDIENCEX Steve Bligh-WIlliams Director, Paid Media Media Agency Aurum Producciones SA Tara Craze VP, Digital Media Agency Aurum Producciones SA Nora Okonski Senior Director, Revenue Operations Publisher Axios Kathleen Pratt Director, Ad Operations Publisher Axios Media Terri Schriver SVP Enterprise Customer Engagement & Investment Advertiser Bank of America paul D'Urso Head of Digital Taxonomy and Projects Publisher Bauer Media Paul Gelb Head of Social and Programmatic Advertiser Bayer Courtney Greenspan Head of AdOps, North America Publisher BBC Melissa Chapman Collaborator Consultancy Beeler Tech LLC Rob Beeler Founder & CEO Consultancy Beeler.Tech Ariel Anderson Media Director Media Agency Best Buy Co., Inc.
    [Show full text]